Sam Barker

Sam Barker is a seasoned professional in the biotechnology sector, currently serving as Chief Business Officer at ViaNautis, where a recent $25 million Series A funding round was announced. Prior to this role, Sam held similar titles at SomaServe and served as Director of Business Development at Midatech (now Biodexa). With extensive experience at PhoreMost Ltd in various managerial and scientific positions, including Senior Business Development & Alliance Manager, Sam has a strong background in identifying novel drug targets. Academic credentials include a Ph.D. in Drug Discovery from the University of Exeter, along with business training from Cambridge Judge Business School.